Argonde C. van Harten

Subjective cognitive decline and risk of MCI

Argonde C. van Harten, Michelle M. Mielke, Dana M. Swenson-Dravis et al. · Neurology · 2018 · 313 citations · Full text

Medicine, Neurology, Psychology +17

ATN classification and clinical progression in subjective cognitive decline

Jarith L. Ebenau, Tessa Timmers, Linda M.P. Wesselman et al. · Neurology · 2020 · 200 citations · Full text

Medicine, Neurology, Neuroscience +17

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

Argonde C. van Harten, Pieter Jelle Visser, Yolande A.L. Pijnenburg et al. · Alzheimer s & Dementia · 2012 · 196 citations · Full text

Medicine, Neurology, Neuroscience +17

Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects

Jon B. Toledo, Henrik Zetterberg, Argonde C. van Harten et al. · Brain · 2015 · 142 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Preclinical AD predicts decline in memory and executive functions in subjective complaints

Argonde C. van Harten, Lieke Smits, Charlotte E. Teunissen et al. · Neurology · 2013 · 140 citations

Medicine, Neurology, Neuroscience +17